All Stories

  1. Genome Sequence of the Psychrophilic Bacterium Tenacibaculum ovolyticum Strain da5A-8 Isolated from Deep Seawater
  2. Genome Sequence of a Carbapenem-Resistant Strain of Ralstonia mannitolilytica
  3. Vibrio cholerae T3SS Effector VopE Modulates Mitochondrial Dynamics and Innate Immune Signaling by Targeting Miro GTPases
  4. First Report of Metallo-β-Lactamase NDM-5-Producing Escherichia coli in Japan
  5. Shigella IpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages
  6. Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection
  7. Emergence of third‐generation cephalosporin‐resistant Enterobacteriacae in a Japanese critical care setting
  8. Distribution of carbapenem resistance determinants among epidemic and non-epidemic types of Acinetobacter species in Japan
  9. Chromobacterium violaceum nosocomial pneumonia in two Japanese patients at an intensive care unit
  10. Evaluation of a Double-Disk Synergy Test with a Common Metallo-^|^beta;-Lactamase Inhibitor, Mercaptoacetate, for Detecting NDM-1-Producing Enterobacteriaceae and Acinetobacter baumannii
  11. A subclass B3 metallo- -lactamase found in Pseudomonas alcaligenes
  12. Genome Sequence of a Strain of the Human Pathogenic Bacterium Pseudomonas alcaligenes That Caused Bloodstream Infection
  13. Draft Genome Sequence of Helicobacter fennelliae Strain MRY12-0050, Isolated from a Bacteremia Patient
  14. Rapid discrimination of Acinetobacter baumannii international clone II lineage by pyrosequencing SNP analyses of bla OXA-51-like genes
  15. Genome Sequences of Multidrug-Resistant Acinetobacter baumannii Strains from Nosocomial Outbreaks in Japan
  16. Detection of Tripoli metallo- -lactamase 2 (TMB-2), a variant of blaTMB-1, in clinical isolates of Acinetobacter spp. in Japan
  17. Shigella Targets Epithelial Tricellular Junctions and Uses a Noncanonical Clathrin-Dependent Endocytic Pathway to Spread Between Cells
  18. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response
  19. Faculty Opinions recommendation of Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon.
  20. Attenuated CagA Oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon
  21. Type III Secretion Is Essential for the Rapidly Fatal Diarrheal Disease Caused by Non-O1, Non-O139 Vibrio cholerae
  22. BabA-mediated Adherence Is a Potentiator of theHelicobacter pyloriType IV Secretion System Activity
  23. Functional Analysis of VopF Activity Required for Colonization in Vibrio cholerae
  24. Faculty Opinions recommendation of Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation.
  25. Helicobacter pylori CagA Phosphorylation-Independent Function in Epithelial Proliferation and Inflammation
  26. The versatility of Shigella effectors
  27. Helicobacter pylori Dampens Gut Epithelial Self-Renewal by Inhibiting Apoptosis, a Bacterial Strategy to Enhance Colonization of the Stomach
  28. An oral Salmonella vaccine promotes the down-regulation of cell surface Toll-like receptor 4 (TLR4) and TLR2 expression in mice
  29. Shigella IpgB1 promotes bacterial entry through the ELMO–Dock180 machinery
  30. Microtubule-Severing Activity of Shigella Is Pivotal for Intercellular Spreading
  31. Interaction of CagA with Crk plays an important role in Helicobacter pylori –induced loss of gastric epithelial cell adhesion
  32. IpgB1 Is a Novel Shigella Effector Protein Involved in Bacterial Invasion of Host Cells
  33. Lon, a Stress-Induced ATP-Dependent Protease, Is Critically Important for Systemic Salmonella enterica Serovar Typhimurium Infection of Mice
  34. Oral Immunization with ATP-Dependent Protease-Deficient Mutants Protects Mice against Subsequent Oral Challenge with Virulent Salmonella enterica Serovar Typhimurium
  35. The ClpXP ATP-Dependent Protease Regulates Flagellum Synthesis in Salmonella enterica Serovar Typhimurium
  36. Novel Fosfomycin Resistance of Pseudomonas aeruginosa Clinical Isolates Recovered in Japan in 1996